Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

1.

Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.

Chaudhuri R, McSharry C, Brady J, Donnelly I, Grierson C, McGuinness S, Jolly L, Weir CJ, Messow CM, Spears M, Miele G, Nocka K, Crowther D, Thompson J, Brannigan M, Lafferty J, Sproule M, Macnee W, Connell M, Murchison JT, Shepherd MC, Feuerstein G, Miller DK, Thomson NC.

J Allergy Clin Immunol. 2012 Mar;129(3):655-663.e8. doi: 10.1016/j.jaci.2011.12.996. Epub 2012 Feb 2. Erratum in: J Allergy Clin Immunol. 2013 Jun;131(6):1716.

PMID:
22305682
[PubMed - indexed for MEDLINE]
2.
3.

Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.

Culpitt SV, Rogers DF, Traves SL, Barnes PJ, Donnelly LE.

Respir Med. 2005 Jun;99(6):703-10. Epub 2004 Dec 13.

PMID:
15878486
[PubMed - indexed for MEDLINE]
Free Article
4.

Association between markers of emphysema and more severe chronic obstructive pulmonary disease.

Boschetto P, Quintavalle S, Zeni E, Leprotti S, Potena A, Ballerin L, Papi A, Palladini G, Luisetti M, Annovazzi L, Iadarola P, De Rosa E, Fabbri LM, Mapp CE.

Thorax. 2006 Dec;61(12):1037-42. Epub 2006 Jun 12.

PMID:
16769715
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.

Babusyte A, Stravinskaite K, Jeroch J, Lötvall J, Sakalauskas R, Sitkauskiene B.

Respir Res. 2007 Nov 14;8:81.

PMID:
18001475
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Airway remodeling assessed by high-resolution computed tomography in patients with asthma: relationship to biological markers in induced sputum].

Wu SM, Li CE, Cai RP, Zhang Q, Xu YJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2012 Dec;35(12):892-6. Chinese.

PMID:
23328178
[PubMed - indexed for MEDLINE]
7.

High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.

Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F.

Mol Med. 2011;17(7-8):807-15. doi: 10.2119/molmed.2010.00173. Epub 2011 Mar 3.

PMID:
21380479
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD.

Vignola AM, Paganin F, Capieu L, Scichilone N, Bellia M, Maakel L, Bellia V, Godard P, Bousquet J, Chanez P.

Eur Respir J. 2004 Dec;24(6):910-7.

PMID:
15572531
[PubMed - indexed for MEDLINE]
Free Article
9.

Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD.

Haq I, Lowrey GE, Kalsheker N, Johnson SR.

Thorax. 2011 Nov;66(11):970-6. doi: 10.1136/thx.2011.159087. Epub 2011 Jul 5.

PMID:
21730350
[PubMed - indexed for MEDLINE]
10.

Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputum.

LaPan P, Brady J, Grierson C, Fleming M, Miller D, Sypek J, Fu B.

BMC Pulm Med. 2010 Aug 2;10:40. doi: 10.1186/1471-2466-10-40.

PMID:
20678199
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years.

Miller M, Cho JY, Pham A, Friedman PJ, Ramsdell J, Broide DH.

Chest. 2011 Jun;139(6):1380-7. doi: 10.1378/chest.10-0705. Epub 2010 Oct 21.

PMID:
20966041
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression.

Baraldo S, Bazzan E, Zanin ME, Turato G, Garbisa S, Maestrelli P, Papi A, Miniati M, Fabbri LM, Zuin R, Saetta M.

Chest. 2007 Dec;132(6):1733-40. Epub 2007 Jul 23.

PMID:
17646237
[PubMed - indexed for MEDLINE]
13.

Elevated MMP-12 protein levels in induced sputum from patients with COPD.

Demedts IK, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos GF, Pauwels RA, Brusselle GG.

Thorax. 2006 Mar;61(3):196-201. Epub 2005 Nov 24.

PMID:
16308335
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.

Kirby M, Owrangi A, Svenningsen S, Wheatley A, Coxson HO, Paterson NA, McCormack DG, Parraga G.

Thorax. 2013 Aug;68(8):752-9. doi: 10.1136/thoraxjnl-2012-203108. Epub 2013 Apr 19.

PMID:
23604381
[PubMed - indexed for MEDLINE]
15.

Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.

Vernooy JH, Lindeman JH, Jacobs JA, Hanemaaijer R, Wouters EF.

Chest. 2004 Dec;126(6):1802-10.

PMID:
15596677
[PubMed - indexed for MEDLINE]
16.

Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.

Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M.

Am J Respir Crit Care Med. 2005 Dec 1;172(11):1378-82. Epub 2005 Aug 26.

PMID:
16126934
[PubMed - indexed for MEDLINE]
17.

Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.

Löfdahl JM, Cederlund K, Nathell L, Eklund A, Sköld CM.

Eur Respir J. 2005 Feb;25(2):275-81.

PMID:
15684291
[PubMed - indexed for MEDLINE]
Free Article
19.

MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.

Lowrey GE, Henderson N, Blakey JD, Corne JM, Johnson SR.

Respir Med. 2008 Jun;102(6):845-51. doi: 10.1016/j.rmed.2008.01.006. Epub 2008 Mar 6.

PMID:
18328682
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk